SG Americas Securities LLC Sells 10,764 Shares of STERIS plc $STE

SG Americas Securities LLC trimmed its position in shares of STERIS plc (NYSE:STE) by 44.6% during the 2nd quarter, Holdings Channel reports. The firm owned 13,361 shares of the medical equipment provider’s stock after selling 10,764 shares during the period. SG Americas Securities LLC’s holdings in STERIS were worth $3,210,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of STE. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in STERIS by 7.2% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 24,097 shares of the medical equipment provider’s stock worth $5,789,000 after buying an additional 1,628 shares in the last quarter. Advisors Capital Management LLC boosted its stake in shares of STERIS by 11.1% in the second quarter. Advisors Capital Management LLC now owns 3,404 shares of the medical equipment provider’s stock worth $818,000 after acquiring an additional 339 shares during the period. Police & Firemen s Retirement System of New Jersey grew its position in shares of STERIS by 4.2% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 14,946 shares of the medical equipment provider’s stock worth $3,590,000 after purchasing an additional 608 shares in the last quarter. Geode Capital Management LLC raised its stake in STERIS by 1.9% during the 2nd quarter. Geode Capital Management LLC now owns 2,479,108 shares of the medical equipment provider’s stock valued at $592,980,000 after purchasing an additional 46,859 shares during the period. Finally, Forsta AP Fonden lifted its holdings in STERIS by 34.7% in the 2nd quarter. Forsta AP Fonden now owns 62,500 shares of the medical equipment provider’s stock worth $15,014,000 after purchasing an additional 16,100 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on STE. Morgan Stanley increased their price objective on shares of STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a report on Friday, August 8th. KeyCorp raised their target price on shares of STERIS from $277.00 to $288.00 and gave the company an “overweight” rating in a research note on Tuesday, July 22nd. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. Finally, Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $273.50.

Insider Activity at STERIS

In other STERIS news, CEO Daniel A. Carestio sold 159 shares of the business’s stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $241.82, for a total transaction of $38,449.38. Following the sale, the chief executive officer directly owned 51,096 shares of the company’s stock, valued at $12,356,034.72. The trade was a 0.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP John Adam Zangerle sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the sale, the vice president owned 33,669 shares in the company, valued at approximately $8,926,998.66. This trade represents a 30.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.07% of the company’s stock.

STERIS Trading Up 0.1%

Shares of STE opened at $257.15 on Wednesday. The stock has a market capitalization of $25.24 billion, a PE ratio of 39.38 and a beta of 1.02. The company’s fifty day moving average is $246.32 and its 200 day moving average is $240.93. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.53 and a current ratio of 2.22. STERIS plc has a fifty-two week low of $200.98 and a fifty-two week high of $268.30.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a net margin of 11.61% and a return on equity of 14.17%. The business had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same period last year, the company posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Tuesday, November 18th will be given a $0.63 dividend. The ex-dividend date is Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 1.0%. STERIS’s dividend payout ratio (DPR) is currently 36.21%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.